After Hours
$
77.00
Change
-0.68 -0.88%
Volume
Volume 17,116
Jan 22, 2021, 5:53 p.m.
Quotes are delayed by 20 min
Previous close
$ 76.66
$ 77.68
Change
+1.02 +1.33%
Day low
Day high
$76.45
$78.07

52 week low
52 week high
$32.95
$90.19

Market cap
$4.46B
Average volume
685,677
P/E ratio
N/A
Rev. per Employee
$2.52M
EPS
-7.05
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on ARNA
-
Charting a bullish divergence, Nasdaq extends within view of 10,000 mark
- Michael Ashbaugh
-
Arena Pharmaceuticals upgraded to overweight from neutral at J.P. Morgan
- Tomi Kilgore
-
Arena Pharmaceuticals started at neutral with $51 stock price target at BofA Merrill Lynch
- Tomi Kilgore
-
Five outperforming health-care funds and the top 10 stocks they hold
- Philip van Doorn
-
Arena Pharmaceuticals shares tick lower on secondary offering
- Wallace Witkowski
-
S&P 500 edges to uncharted territory, latest slow-motion breakout underway
- Michael Ashbaugh
-
- Barron's Online
-
Arena Pharma shares retreat slightly on secondary share offering
- Wallace Witkowski
-
Arena Pharma Soars On Lung Disease Drug Study Results
- Barrons Blogs
-
Arena Pharmaceuticals stock price target raised to $53 from $47 at Leerink
- Tomi Kilgore
-
Arena Pharmaceuticals jumps 30% after positive drug study
- MarketWatch
-
Arena Pharmaceuticals started at outperform with $5 stock price target at Leerink
- Tomi Kilgore
-
Arena Pharmaceuticals started at outperform with $6 stock price target at FBR & Co.
- Tomi Kilgore
- Loading more headlines...
Analyst Ratings
-
Benzinga's Top Upgrades, Downgrades For March 20, 2018
- Benzinga.com
-
Arena Pharma Upgraded Ahead Of Clinical Data Release
- Benzinga.com
-
Benzinga's Top Upgrades, Downgrades For January 3, 2018
- Benzinga.com
Other News on ARNA
-
Steven Cohen Boosts Health Care Exposure With 2 Biotech Stocks
- GuruFocus.com
-
INO, ACB, REV and OGI among midday movers
- Seeking Alpha
-
Notable earnings after Monday's close
- Seeking Alpha
-
Arena Pharmaceuticals Q3 2020 Earnings Preview
- Seeking Alpha
-
IPO Update: NLS Pharmaceutics Readies $20 Million IPO Plan
- Seeking Alpha
-
Analyzing Arena Pharmaceuticals's Unusual Options Activity
- benzinga.com
-
Arena Pharma completes enrollment in mid-stage Captivate trial
- Seeking Alpha
- Loading more headlines...
Earnings Announcement
Press Releases on ARNA
-
Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- BusinessWire - BZX
-
Narcolepsy Therapeutics Market Size, Share to accrue $ 3263.65 Million by 2025 - Industry News
- Market Insight Reports
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com